TGFB1 and myocardial infarction: Inhibition of TGF-β activity before MI reduces the effectiveness of scar formation, leading to increased ventricular dilatation, decreased cardiac function and higher mortality rates, whereas TGF-β inhibition at later times after MI reduces adverse reactive fibrosis [62,63].